{"nct_id":"NCT03298451","title":"Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2017-10-11","start_date_type":"ACTUAL","primary_completion_date":"2021-08-27","primary_completion_date_type":"ACTUAL","completion_date":"2026-08-27","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}